Coagulation monitoring during extracorporeal membrane oxygenation: the role of thrombelastography.

Patients undergoing extracorporeal membrane oxygenation (ECMO) are at an increased risk for developing coagulopathies due to the adverse effects of extracorporeal circulation on the hemostatic mechanism. Methods of determining causative factors of bleeding diathesis are often inconsistent and non-specific. ECMO patients require aggressive transfusion therapy with autogenic blood products to stabilize and maintain hemostasis. The present study evaluated the coagulation status of newborn patients undergoing ECMO therapy, using a viscoelastic monitor (Thrombelastograph -TEG) that measures functional aspects of clot development and stabilization. Seventeen neonatal patients undergoing ECMO for severe respiratory dysfunction were entered into this study. Serial blood samples were obtained and routine coagulation assessment including fibrinogen concentration, platelet count and ionized calcium was performed. In addition, fibrin(ogen) degradation products (FDP), d-Dimers, antithrombin III and plasma free hemoglobin were measured. Transfusion indicators were established and total transfusion requirements recorded. TEG profiles were determined with the use of heparinase, an enzyme that degrades heparin but has little effect on other coagulation factors. The most commonly encountered complication was hemorrhaging which was diagnosed by laboratory and clinical assessment in 11 of 17 patients. Transfusion requirements (measured in ml/kg/ECMO hour) were the following: packed red blood cells--1.34 +/- 0.5; platelets--0.71 +/- 0.57; fresh frozen plasma--0.09 +/- 0.12; cryoprecipitate 0.05 +/- 0.05. Thrombelastograph profiles reflected hemostatic conditions that ranged from severe coagulopathies (DIC) to hypercoagulability. Interpretation of TEG profiles identified hemostatic abnormalities in 57 of 101 profiles (46.5%), with the most common etiology related to platelet dysfunction.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  G. Gravlee,et al.  Predictive value of blood clotting tests in cardiac surgical patients. , 1995, The Annals of thoracic surgery.

[2]  R. McCarthy,et al.  Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay. , 1994, Journal of cardiothoracic and vascular anesthesia.

[3]  W. Williams,et al.  Thrombin regulation in congenital heart disease after cardiopulmonary bypass operations. , 1994, The Journal of thoracic and cardiovascular surgery.

[4]  I. Jarjour,et al.  Cerebrovascular lesions in infants and children dying after extracorporeal membrane oxygenation. , 1994, Pediatric neurology.

[5]  B. Smith,et al.  Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass. , 1994, The Journal of thoracic and cardiovascular surgery.

[6]  N. Payne,et al.  Predictive Performance of Three Methods of Activated Clotting Time Measurement in Neonatal ECMO Patients , 1993, ASAIO journal (1992).

[7]  R. Arensman,et al.  Extracorporeal Life Support , 1993 .

[8]  S. C. Faulkner,et al.  Trouble shooting the extracorporeal membrane oxygenator circuit and patient. , 1993, The journal of extra-corporeal technology.

[9]  M. Fallat,et al.  Surgical complications and procedures in neonates on extracorporeal membrane oxygenation. , 1992, Journal of pediatric surgery.

[10]  R. Bartlett,et al.  Platelet consumption during neonatal extracorporeal life support (ECLS) , 1992 .

[11]  Lawrence M. Fagan,et al.  Anticoagulation therapy advisor: a decision-support system for heparin therapy during ECMO. , 1992, Proceedings. Symposium on Computer Applications in Medical Care.

[12]  M. Hirthler,et al.  Coagulation parameter instability as an early predictor of intracranial hemorrhage during extracorporeal membrane oxygenation. , 1992, Journal of pediatric surgery.

[13]  F. Horkay,et al.  Monitoring of coagulation status using thrombelastography during paediatric open heart surgery , 1991, International journal of clinical monitoring and computing.

[14]  R. Steinhorn,et al.  Whole blood activated clotting time in infants during extracorporeal membrane oxygenation. , 1990, Critical care medicine.

[15]  R. Cipolle,et al.  Procedural variables which affect activated clotting time test results during extracorporeal membrane oxygenation therapy. , 1989, Critical Care Medicine.

[16]  P. Powers,et al.  Development of the human coagulation system in the full-term infant. , 1987, Blood.

[17]  M. Klein,et al.  Hemorrhagic complications during extracorporeal membrane oxygenation: prevention and treatment. , 1986, Journal of pediatric surgery.

[18]  L. Harker Bleeding after cardiopulmonary bypass. , 1986, The New England journal of medicine.

[19]  J H Lewis,et al.  Intraoperative Changes in Blood Coagulation and Thrombelastographic Monitoring in Liver Transplantation , 1985, Anesthesia and analgesia.

[20]  J. Ware,et al.  Defective platelet aggregation in patients undergoing surgical repair of cyanotic congenital heart disease. , 1983, The Annals of thoracic surgery.

[21]  P. Heneberg,et al.  [Anesthesia in pediatric cardiac surgery]. , 1983, Rozhledy v Chirurgii.

[22]  I. Fisch,et al.  Oral Contraceptives, ABO Blood Groups, and In Vitro Fibrin Formation , 1975, Obstetrics and Gynecology.

[23]  W. Künzer [Blood coagulation and its disorders in the newborn]. , 1971, Klinische Wochenschrift.

[24]  I. Nilsson,et al.  FIBRINOLYSIS IN NEWBORNS , 1970, Acta paediatrica Scandinavica.